hyperlipidemia
Conditions
Interventions
treatment group:chinese herbs
control group:placebo
Sponsors
Baokang Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Male
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: age:18-75 years old;1.70 mmol/L (150mg/dl)< TG<4.52 mmol/L (399 mg/dl);LDL-C=3.37mmol/L;voluntarily signning informed consent.
Exclusion criteria
Exclusion criteria: Secondary dyslipidemia; Taking other drugs for treatment; Fast glucose =180mg/dl (10mmol/L), or HbA1C>8%; DBP>115mmHg?SBP>180mmHg; Active liver disease; ALT or/and AST was over the normal range 1.5 folds; Severe renal dysfunction (e.g.Creatinine clearance is less than the normal value of 25%); Combined with other serious primary diseases such as endocrine, hematopoietic system; Symptomatic cerebrovascular disease or new myocardial infarction in the past 3 months; Preparing fertility, pregnancy or lactation women in the future 3 months; Allergic constitution, or known allergic to any ingredient of the intervention; Taking part in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum lipid;Concentration of Br2+;medication adherence scal; | — |
Secondary
| Measure | Time frame |
|---|---|
| side effect; | — |
Countries
China
Contacts
Public ContactZhang Junhua
Outcome results
None listed